117 related articles for article (PubMed ID: 2339202)
1. Changes in urinary thromboxane level in man during cardiopulmonary bypass: effect of thromboxane on renal tubules.
Arima T; Shiramatsu T; Matsuura M; Nakamura S; Matsumoto I; Hori T
Prostaglandins; 1990 Mar; 39(3):319-38. PubMed ID: 2339202
[TBL] [Abstract][Full Text] [Related]
2. [Effect of TXA2 on renal lysosomal membrane].
Arima T; Matsumoto I; Hori T
Masui; 1989 Dec; 38(12):1567-73. PubMed ID: 2614884
[TBL] [Abstract][Full Text] [Related]
3. [Changes in urinary immunoreactive-TXB2 and 2,3-dinor TXB2 in man following cardiopulmonary bypass].
Arima T; Ueda K; Genda T; Omoto R; Matsumoto I; Hori T
Masui; 1989 Apr; 38(4):512-6. PubMed ID: 2724515
[TBL] [Abstract][Full Text] [Related]
4. [Changes in urinary prostaglandins during cardiopulmonary bypass in man].
Arima T; Ohata M; Matsuura M; Nakamura S; Matsumoto I; Hori T
Masui; 1989 Jul; 38(7):908-12. PubMed ID: 2614902
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites.
Laffi G; Marra F; Carloni V; Azzena G; De Feo ML; Pinzani M; Tosti-Guerra C; Gentilini P
Gastroenterology; 1992 Sep; 103(3):1017-21. PubMed ID: 1386823
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass.
Jörres A; Chiabrando C; Kordonouri O; Schiessler A; Hess S; Farke S; Gahl GM; Müller C; Rivoltella L; Djurup R
Eicosanoids; 1992; 5(3-4):147-51. PubMed ID: 1292525
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass.
Jörres A; Kordonouri O; Schiessler A; Hess S; Farke S; Gahl GM; Müller C; Djurup R
Artif Organs; 1994 Aug; 18(8):565-9. PubMed ID: 7527629
[TBL] [Abstract][Full Text] [Related]
8. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
[TBL] [Abstract][Full Text] [Related]
10. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass.
Pearl JM; Manning PB; McNamara JL; Saucier MM; Thomas DW
Ann Thorac Surg; 1999 Oct; 68(4):1369-75. PubMed ID: 10543508
[TBL] [Abstract][Full Text] [Related]
11. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
[TBL] [Abstract][Full Text] [Related]
12. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine.
Schweer H; Meese CO; Fürst O; Kühl PG; Seyberth HW
Anal Biochem; 1987 Jul; 164(1):156-63. PubMed ID: 3674365
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
[TBL] [Abstract][Full Text] [Related]
14. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog.
Mathie RT; Fleming JS; Barrow SE; Arnold JV; Brannan JJ; Becket JM; Ritter JM; Taylor KM
Perfusion; 1995 Nov; 10(6):403-13. PubMed ID: 8747897
[TBL] [Abstract][Full Text] [Related]
15. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs.
Yamanaka S; Miura K; Yukimura T; Yamamoto K
Prostaglandins; 1993 Mar; 45(3):221-8. PubMed ID: 8484010
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
17. Effects of cisplatin on urinary thromboxane B2 excretion.
Blöchl-Daum B; Pehamberger H; Kurz C; Kyrle PA; Wagner O; Müller M; Monitzer B; Eichler HG
Clin Pharmacol Ther; 1995 Oct; 58(4):418-24. PubMed ID: 7586934
[TBL] [Abstract][Full Text] [Related]
18. Changes in platelet calcium concentration by thromboxane A2 stimulation in patients with nephrotic syndrome of childhood.
Kobayashi T; Suzuki J; Watanabe M; Suzuki S; Yoshida K; Kume K; Suzuki H
Nephron; 1997; 77(3):309-14. PubMed ID: 9375825
[TBL] [Abstract][Full Text] [Related]
19. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators.
Hashimoto K; Miyamoto H; Suzuki K; Horikoshi S; Matsui M; Arai T; Kurosawa H
J Thorac Cardiovasc Surg; 1992 Sep; 104(3):666-73. PubMed ID: 1355150
[TBL] [Abstract][Full Text] [Related]
20. [The effects of thromboxane receptor antagonist on hemodynamic responses after neutralization of heparin by protamine].
Yoshioka M; Wakamatsu M; Kuro M; Okumura F
Masui; 1991 Jun; 40(6):918-22. PubMed ID: 1875538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
